Loading provider…
Loading provider…
Nuclear Radiology Physician in Clearwater, FL
NPI: 1336154608Primary Practice Location
Carlisle Imaging Center
400 Pinellas St, Clearwater, FL
Primary Employer
Carlisle Imaging Center
radiologyclearwater.com
HQ Phone
Get MD John's Phone NumberMobile
Get MD John's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1993 - 2027
TX State Medical License
2001 - 2007

American Board of Nuclear Medicine
Nuclear Medicine

National Board of Physicians and Surgeons
Nuclear Medicine
San Antonio Uniformed Services Health Education Consortium (SAUSHEC)
Residency • Nuclear Medicine
1995 - 1997
Tripler Army Medical Center
Residency • Internal Medicine
1992 - 1995
USF Health Morsani College of Medicine
health.usf.edu
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 774 | 965 |
| 2 | 78815Nuclear medicine study with CT imaging skull base to mid-thigh | 709 | 884 |
| 3 | 78306Bone and/or joint imaging, whole body | 265 | 275 |
| 4 | 78227Imaging of liver and bile duct system with use of drugs | 158 | 159 |
| 5 | A9537Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 144 | 145 |
A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
Authors: Harry Bear, David Mankoff
Publication Date: 2015-11
A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.
Authors: Daniel Pryma, Paul Jolles, Harry Bear, Jennifer Specht
Publication Date: 2015-05-11
Soft tissue metastases and lung cancer recurrence detected by Tc-99m depreotide scintigraphy.
Authors: Miliziano, John S, Bradley, Yong C
Journal: Clin Nucl Med
Lead Sponsor: Molecular Insight Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: 99mTc-MIP-1404 Injection, DIAGNOSTIC_TEST: Whole-Body Planar and pelvic SPECT/CT scan